Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pharma's vaccine epidemic
Investors Chronicle
Tuesday, January 19, 2010 - 10:15am
tags:
vaccines, GSK
Indian biotech exec predicts a $10B industry boomInd
Fierce Biotech
Tuesday, January 19, 2010 - 10:08am
tags:
India, biotech
Glaxo troubled by flu cuts, fake Alli
Fierce Pharma
Tuesday, January 19, 2010 - 10:06am
tags:
Alli, GSK, swine flu, vaccines, H1N1
The Top Biotech Layoffs of 2009...and a Silver Lining
BNET Pharma
Tuesday, January 19, 2010 - 9:42am
tags:
biotech, layoffs, Sepracor, Allergan, Genmab, Oscient, Amylin
Musings on Commando Teva: Besting Big Pharma?
InVivo
Tuesday, January 19, 2010 - 9:41am
tags:
Teva Pharmaceuticals
Digging Deeper into Adventrx Pharmaceuticals
TheStreet.com
Tuesday, January 19, 2010 - 9:39am
tags:
Adventrx, Genentech, Novartis, Amgen, Pfizer, Novelos Therapeutics, ONYX Pharmaceuticals
Genzyme: Shire Chomping at the Bit
Seeking Alpha
Tuesday, January 19, 2010 - 9:36am
tags:
Shire, Genzyme, Amicus Therapeutics
New Illumina Genome Sequencer Dramatically Slashes Costs, Time
Seeking Alpha
Tuesday, January 19, 2010 - 9:34am
tags:
Illumina, genome sequencer, Helicos, Life Technologies
Pfizer, Teva set to tussle for Ratiopharm
Reuters
Tuesday, January 19, 2010 - 9:32am
tags:
Teva Pharmaceuticals, Pfizer, Ratiopharm, M&A
AspenBio Pharma Poised for a Breakout Year
Seeking Alpha
Tuesday, January 19, 2010 - 9:30am
tags:
AspenBio
Sangamo Says Experimental Therapy Kept HIV Level Low in Patient
Bloomberg
Tuesday, January 19, 2010 - 9:28am
tags:
HIV, Sangamo BioSciences
Forest Labs earnings per share 69 cents
Marketwatch
Tuesday, January 19, 2010 - 9:27am
tags:
Forest Labs, earnings
J&J Has Success with Psoriasis Treatment
Seeking Alpha
Tuesday, January 19, 2010 - 9:23am
tags:
psoriasis, JNJ, Amgen, Abbott Laboratories, Enbrel, Humira, Stelara
The Long Case for Pfizer
Seeking Alpha
Tuesday, January 19, 2010 - 9:05am
tags:
Pfizer
GlaxoSmithKline donates antibiotics to Haiti
Bizjournals.com
Tuesday, January 19, 2010 - 9:04am
tags:
donations, Haiiti, GSK
King Pharmaceuticals Faces Setbacks With 'Abuse-Resistant' Pain Medicines
BNET Pharma
Monday, January 18, 2010 - 12:41pm
tags:
King, pain management
The Future of Biotech: Party Like It's 1999
Seeking Alpha
Monday, January 18, 2010 - 12:14pm
tags:
Amgen, Genzyme, Biogen Idec, Celgene, Gilead Sciences, Teva Pharmaceuticals, Watson Pharmaceuticals, OSI Pharmaceuticals, Sunesis, Amag Pharmaceuticals, Jazz Pharmaceuticals, Indenix, Inspire, Novavax, Cyclacel, Cardica, Micromet, Rosetta Genomics
At Genzyme, a Long View
NY Times, NY
Monday, January 18, 2010 - 12:13pm
tags:
Genzyme
Isis Expands Pipeline
Yahoo/Zacks.com
Monday, January 18, 2010 - 12:10pm
tags:
Isis Pharmaceuticals, pipelines
Glaxo Sees 10% Growth in Asia This Year on Emerging Markets
Bloomberg
Monday, January 18, 2010 - 12:08pm
tags:
GSK, Asia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.